Insider trade

CEO sold ~$1.82M of CRL shares in the open market

Traded Aug 11, 2026 · Filed Aug 13, 2026

~$1.82M
Reported value · 6,500 sh @ $279.90: 36K
Holds after · shares reported: +1.7%
stock since the trade · S&P 500 -0.8%, $282.00 → $286.83 on Oct 1

Why it stands out

The boss of Charles River Laboratories sold $1.82M of Charles River Laboratories shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 11, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 13, 2026

CEO$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,819,350

Shares × reported transaction price

Timing vs results

6 days after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $282.00 on Aug 11, 2026, at its 52-week high, after a 25% rise over the previous 30 trading days

52-week range $145.57 (Sep 25, 2025) to $282.00 (Aug 11, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $225.57 on Jun 29, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+5.4%	-1.4%	+6.8%
30 days	-2.5%	-2.0%	-0.5%

Past results only. Not a forecast.

Source receipt

Record ID: 0001100682-26-000132
Filed / recorded: Aug 13, 2026, 8:37 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Issuer CIK: 1100682
Ticker: CRL
Reporting person: Birgit Girshick
Relationship: Director, Officer
Officer title: Chief Executive Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Aug 11, 2026
Transaction code: S
Shares / units: 6,500
Price per share: $279.90
Acquired / disposed: Disposed (D)
Shares owned after: 36,013
Ownership form: Direct
Amendment: No

Footnotes from the filing

This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 3, 2025.

Around the same time

5w ago

21KShares · @ $194.12

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record